- Mydecine Innovations Group press release ( OTCPK:MYCOF ): Q3 GAAP EPS of -$0.35.
- The company had $0.08M in cash and cash equivalents as of September 30, 2022.
For further details see:
Mydecine Innovations Group GAAP EPS of -$0.35home / stock / mycof / mycof news
For further details see:
Mydecine Innovations Group GAAP EPS of -$0.35Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
New Age Brands Company Name:
MYCOF Stock Symbol:
Market:
(TheNewswire) VANCOUVER, British Columbia – TheNewswire - April 25, 2024 — Mydecine Innovations Group Inc. (the “ Company ”) (CSE:MYCO) (FSE:0NF0) (OTC:MYCOF) (AQSE:MYIG) announces that as a result of a review by the British Columbia...
(TheNewswire) VANCOUVER, BC – TheNewswire - (15 April 2024 ) Mydecine Innovations Group Inc . (CSE: MYCO) (AQSE: MYIG) (FSE: 0NFA) (OTC: MYCOF) (the “ Company ” or “ Mydecine ”) announces that it has closed two d...
(TheNewswire) V ANCOUVER, BC – ( TheNewswire / 27 March 2024 ) Mydecine Innovations Group Inc . (CSE: MYCO) (AQSE: MYIG) (FSE: 0NFA) (OTC: MYCOF) (the “ Company ” or “ Mydecine ”) announces that it has closed...